Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!

If you are interested in the 2024 event, please get in touch at info@hansonwade.com

5th Gene Therapy for Neurological Disorders Summit Full Event Guide
5th Gene Therapy for Neurological Disorders Summit Slogan

Welcome to the 5th Gene Therapy for Neurological Disorders Summit

Accelerating More Transformative Gene Therapies for CNS Disorders

Recent approvals from Sarepta, Bluebird Bio, and PTC Therapeutics, and news of expanding CNS pipelines have highlighted the popular interest in the next-generation of neurological gene therapies, so at the 5th Gene Therapy for Neurological Disorders Summit attendees were helped to propel their selves into the next wave of innovation.

This meeting helped attendees to overcome Discovery, Preclinical and Clinical Development, and regulatory challenges, from capsid engineering to preclinical model selection, immunogenicity, drug delivery, and regulation. The comprehensive 3-day discussion was full of need-to-know and practical insights. 

Now that the neurological gene therapy field has been given a renewed sense of direction, this summit gave attendees the opportunity to capitalize on the start of a new wave of innovation and optimize the potential for gene therapies targeting neurological disorders.

 

Companies Who Attended in 2023 Included:

Companies Attending
Companies Attending
Companies Attending
Companies Attending
Companies Attending

Past Testimonials:

PTC Therapeutics Logo

"The breadth of experience and extremely relevant topics to gene therapy. Definitely planning to attend next year, I learned a lot!"- Alexis Russel

The 2023 Lead Partner

2023 Partners

Other Events in the Gene Therapy Series

Other Events in the CNS Series

Quick Links